ID: ALA601619

Max Phase: Preclinical

Molecular Formula: C18H29F2N4O4P

Molecular Weight: 434.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOP(=O)(OCC)C(F)(F)CCCCCCCc1c[nH]c2c(=O)[nH]c(N)nc12

Standard InChI:  InChI=1S/C18H29F2N4O4P/c1-3-27-29(26,28-4-2)18(19,20)11-9-7-5-6-8-10-13-12-22-15-14(13)23-17(21)24-16(15)25/h12,22H,3-11H2,1-2H3,(H3,21,23,24,25)

Standard InChI Key:  ZZPPPMLAIPJXSY-UHFFFAOYSA-N

Associated Targets(Human)

Purine nucleoside phosphorylase 774 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Purine nucleoside phosphorylase 323 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 434.42Molecular Weight (Monoisotopic): 434.1894AlogP: 4.58#Rotatable Bonds: 13
Polar Surface Area: 123.09Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.23CX Basic pKa: 5.14CX LogP: 3.15CX LogD: 3.15
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.31Np Likeness Score: 0.06

References

1. Hikishima S, Hashimoto M, Magnowska L, Bzowska A, Yokomatsu T..  (2010)  Structural-based design and synthesis of novel 9-deazaguanine derivatives having a phosphate mimic as multi-substrate analogue inhibitors for mammalian PNPs.,  18  (6): [PMID:20189401] [10.1016/j.bmc.2010.01.062]

Source